Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,784 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Angiographic results of the first human experience with everolimus-eluting stents for the treatment of coronary lesions (the FUTURE I trial).
Costa RA, Lansky AJ, Mintz GS, Mehran R, Tsuchiya Y, Negoita M, Gilutz Y, Nikolsky E, Fahy M, Pop R, Cristea E, Carlier S, Dangas G, Stone GW, Leon MB, Müller R, Techen G, Grube E. Costa RA, et al. Among authors: mehran r. Am J Cardiol. 2005 Jan 1;95(1):113-6. doi: 10.1016/j.amjcard.2004.08.074. Am J Cardiol. 2005. PMID: 15619406 Clinical Trial.
Effect of everolimus-eluting stents in different vessel sizes (from the pooled FUTURE I and II trials).
Tsuchiya Y, Lansky AJ, Costa RA, Mehran R, Pietras C, Shimada Y, Sonoda S, Cristea E, Negoita M, Dangas GD, Moses JW, Leon MB, Fitzgerald PJ, Müller R, Störger H, Hauptmann KE, Grube E. Tsuchiya Y, et al. Among authors: mehran r. Am J Cardiol. 2006 Aug 15;98(4):464-9. doi: 10.1016/j.amjcard.2006.02.054. Epub 2006 Jun 19. Am J Cardiol. 2006. PMID: 16893698 Clinical Trial.
5-year clinical outcomes after sirolimus-eluting stent implantation insights from a patient-level pooled analysis of 4 randomized trials comparing sirolimus-eluting stents with bare-metal stents.
Caixeta A, Leon MB, Lansky AJ, Nikolsky E, Aoki J, Moses JW, Schofer J, Morice MC, Schampaert E, Kirtane AJ, Popma JJ, Parise H, Fahy M, Mehran R. Caixeta A, et al. Among authors: mehran r. J Am Coll Cardiol. 2009 Sep 1;54(10):894-902. doi: 10.1016/j.jacc.2009.04.077. J Am Coll Cardiol. 2009. PMID: 19712798 Free article.
Two-year safety and effectiveness of sirolimus-eluting stents (from a prospective registry).
Claessen BE, Mehran R, Leon MB, Heller EA, Weisz G, Syros G, Mintz GS, Franklin-Bond T, Apostolidou I, Henriques JP, Stone GW, Moses JW, Dangas GD. Claessen BE, et al. Among authors: mehran r. Am J Cardiol. 2011 Feb 15;107(4):528-34. doi: 10.1016/j.amjcard.2010.10.010. Epub 2010 Dec 31. Am J Cardiol. 2011. PMID: 21195378 Clinical Trial.
Impact of the everolimus-eluting stent on stent thrombosis: a meta-analysis of 13 randomized trials.
Baber U, Mehran R, Sharma SK, Brar S, Yu J, Suh JW, Kim HS, Park SJ, Kastrati A, de Waha A, Krishnan P, Moreno P, Sweeny J, Kim MC, Suleman J, Pyo R, Wiley J, Kovacic J, Kini AS, Dangas GD. Baber U, et al. Among authors: mehran r. J Am Coll Cardiol. 2011 Oct 4;58(15):1569-77. doi: 10.1016/j.jacc.2011.06.049. Epub 2011 Sep 14. J Am Coll Cardiol. 2011. PMID: 21924575 Free article.
Dedicated two-stent technique in complex bifurcation percutaneous coronary intervention with use of everolimus-eluting stents: the EES-bifurcation study.
Kherada NI, Sartori S, Tomey MI, Mennuni MG, Meelu OA, Roy S, Mohanty BD, Baber U, Pyo R, Kovacic JC, Sweeny J, Moreno P, Krishnan P, Dangas GD, Mehran R, Sharma SK, Kini AS. Kherada NI, et al. Among authors: mehran r. Int J Cardiol. 2014 Jun 1;174(1):13-7. doi: 10.1016/j.ijcard.2014.03.029. Epub 2014 Mar 15. Int J Cardiol. 2014. PMID: 24731975
Antiplatelet therapy after drug-eluting stent implantation.
Warren J, Baber U, Mehran R. Warren J, et al. Among authors: mehran r. J Cardiol. 2015 Feb;65(2):98-104. doi: 10.1016/j.jjcc.2014.10.006. Epub 2014 Nov 6. J Cardiol. 2015. PMID: 25467922 Free article. Review.
1,784 results